Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges

Ruth Jessen Hickman, MD  |  Issue: June 2017  |  June 15, 2017

Leonard H. Calbrese, DO, FACR, is a professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. He has extensive experience treating HIV-positive patients as a rheumatologist. “Rheumatologists need to keep this on their radar screen, because there is an aging HIV population that will need care for rheumatic problems that may be totally unrelated to HIV infection, but they have underlying HIV, and that is quite an important co-morbidity,” he explains. “The rheumatic complications of HIV infection itself are decreasing; these are relatively rare complications, but the aging HIV population with gout or osteoarthritis or back pain—these are important.”

A Complex Picture

For practicing rheumatologists, the picture remains complex. We have a relatively poor understanding of the prevalence of various rheumatic conditions in HIV. Epidemiological studies of rheumatic symptoms in the cART era have reported widely different numbers, as recently reviewed.3,4 For example, Hochberg and colleagues concluded that reactive arthritis was not more common in people with HIV, unlike previously believed.10 Others have concluded that musculoskeletal symptoms remain common in these patients.11 We lack good data on the true prevalence of many of these syndromes, and this prevalence may be quite different in areas where many patients are not well controlled with cART therapies.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Another reason for complexity is the variety of causes of rheumatic symptoms in HIV-positive persons. Many patients have unrelated rheumatic symptoms that need treatment, but others have symptoms from syndromes triggered by HIV. These may be caused by the illness itself, or secondarily through medication side effects, such as myopathy from zidovudine.12 Some patients with HIV are also at risk of rheumatic syndromes due to infection with other sexually borne illnesses, such as a reactive arthritis resulting from Chlamydia infection. Additionally, a patient with advanced, uncontrolled HIV may present with rheumatic symptoms from an opportunistic infection, or a person with initial seroconversion may show musculoskeletal symptoms.4

Other types of issues can cause rheumatologic issues in these patients. Karen Walker-Bone, BM, FRCP, PhD, Hon FFOM, is an associate professor in occupational rheumatology at the University of Southampton in Southampton, England. She co-authored an article reviewing management of musculoskeletal disorders in people living with HIV. She recommends also keeping in mind other causes of pain more common in people with HIV, such as peripheral neuropathy and opportunistic malignancies.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Much of the pathophysiology between HIV infection and rheumatic syndromes is not well understood. Sometimes, HIV may transiently improve a rheumatic syndrome, or it may make it worse, depending on context.1,3-7

Page: 1 2 3 4 5 6 7 8 9 | Single Page
Share: 

Filed under:ConditionsPractice Support Tagged with:arthralgiascombination antiretroviral therapyDiagnosisdrug interactionHIVMyopathypatient careRheumatic Diseaserheumatologistrheumatologytreament

Related Articles
    HIV Infection: What Rheumatologists Need to Know

    HIV Infection: What Rheumatologists Need to Know

    June 15, 2015

    It has been nearly 35 years since the original descriptions of what now is recognized as AIDS (the acquired immune deficiency syndrome), an advanced form of infection secondary to the human immunodeficiency virus (HIV). The epidemic of HIV infection remains the singular most dramatic epidemic of our generation and will likely remain with us for…

    AFLAR Experts Discuss Highlights, Hurdles in Rheumatology in Africa

    December 18, 2018

    CHICAGO—Rheumatology physicians and researchers from Africa said the field’s resources and medical literature on the continent are slowly expanding, but they repeatedly lamented that the millions who suffer from rheumatic diseases there have major obstacles to overcome to access care. Their reviews and assessments—sometimes grim and sometimes hopeful—came in a session that was a joint…

    APS: What Rheumatologists Should Know about Hughes Syndrome

    February 17, 2016

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    Meet the HEP C Challenge

    December 1, 2008

    Keep a hepatitis C virus infection from hindering RA treatment

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences